Pre-Transplant Rituximab Is Associated with a Greatly Reduced Risk of Epstein-Barr Virus Reactivation Following Allogeneic Stem Cell Transplantation

被引：0
|
作者：
Burns, David [1 ]
Rana, Shabeeha [2 ]
Howman, Andrew [3 ]
Nagra, Sandeep [1 ]
Ward, Janice [1 ]
Osman, Husam [4 ]
Taha, Yusri [5 ,6 ]
Byrne, Jenny [2 ]
Das-Gupta, Emma [2 ]
Raghavan, Manoj [1 ]
Malladi, Ram [1 ]
Cook, Mark [1 ]
Mahendra, Prem [1 ]
Russell, Nigel H. [2 ]
Craddock, Charles [1 ]
Fox, Christopher [2 ]
Chaganti, Sridhar [1 ]
机构：
[1] Univ Hosp Birmingham NHS Trust, Ctr Clin Haematol, Birmingham, W Midlands, England
[2] Nottingham Univ Hosp NHS Trust, Ctr Clin Haematol, Nottingham, England
[3] Univ Birmingham, Canc Res UK Clin Trials Unit, Birmingham, W Midlands, England
[4] Birmingham Heartlands Hosp, Hlth Protect Agcy Lab, Birmingham B9 5ST, W Midlands, England
[5] Nottingham Univ Hosp NHS Trust, Dept Virol, Nottingham, England
[6] Nottingham Univ Hosp NHS Trust, Dept Infect Dis, Nottingham, England
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.460.460
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
460
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Management of Epstein-Barr virus reactivation following allogeneic stem cell transplantation
    Lankester, Arjan C.
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2007, 12 (03) : 163 - 165
  • [2] Subcutaneous administration of rituximab in patients with Epstein-Barr virus reactivation after allogeneic stem cell transplantation
    Klink, A.
    Schmidt, V.
    Dornaus, S.
    Winkelmann, N.
    Sayer, H. G.
    von Lilienfeld-Toal, M.
    Hochhaus, A.
    Hilgendod, I.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S191 - S191
  • [3] Use of Rituximab in Epstein-Barr Virus Infection Following Allogeneic Hematopoietic Stem Cell Transplantation
    Song, Li
    Wang, Pei-Jun
    Zhang, Mei-Ping
    Ji, Chun-Xiao
    Wang, Ling
    Li, Ying
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (05): : 2439 - 2443
  • [4] Mycophenolate mofetil is associated with a reduced risk of Epstein-Barr virus reactivation following renal transplantation
    Haque, Tanzina
    Holmes, Michael
    Atkinson, Claire E.
    Caplin, Ben
    Smith, Colette J.
    Harber, Mark A.
    Sweny, Paul
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 477 - 477
  • [5] Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation
    Zallio, Francesco
    Primon, Valeria
    Tamiazzo, Stefania
    Pini, Massimo
    Baraldi, Anna
    Corsetti, Maria T.
    Gotta, Franca
    Bertassello, Claudia
    Salvi, Flavia
    Rocchetti, Andrea
    Levis, Alessandro
    CLINICAL TRANSPLANTATION, 2013, 27 (04) : E491 - E497
  • [6] Clonal gammopathies and Epstein-Barr virus reactivation after allogeneic stem cell transplantation
    Di Nardo, P.
    Bellesi, S.
    Sora, F.
    Laurenti, L.
    Innocenti, I.
    Chiusolo, P.
    Cattani, P.
    Tarnani, M.
    De Matteis, S.
    Leone, G.
    Sica, S.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S285 - S286
  • [7] Epstein-Barr virus reactivation after allogeneic hematopoietic stem cell transplantation: multifactorial impact on transplant outcomes
    Ru, Yuhua
    Zhang, Xiang
    Song, Tiemei
    Ding, Yiyang
    Zhu, Ziling
    Fan, Yi
    Xu, Yang
    Sun, Aining
    Qiu, Huiying
    Jin, Zhengming
    Tang, Xiaowen
    Han, Yue
    Fu, Zhengzheng
    Chen, Suning
    Ma, Xiao
    Chen, Feng
    Chen, Jia
    Wu, Depei
    BONE MARROW TRANSPLANTATION, 2020, 55 (09) : 1754 - 1762
  • [8] Characteristics of Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein-Barr virus disease: favorable responses to rituximab
    Wei, Na
    Wang, Yini
    Wang, Jingshi
    Wu, Lin
    Wang, Zhao
    BONE MARROW TRANSPLANTATION, 2021, 56 (06) : 1449 - 1451
  • [9] Features of Epstein-Barr virus reactivation after reduced-intensity conditioning allogeneic stem cell transplantation
    Peric, Z.
    Chevallier, P.
    Guillaume, T.
    Delaunay, J.
    Ayari, S.
    Dubruille, V.
    Le Gouill, S.
    Mahe, B.
    Gastinne, T.
    Blin, N.
    Saulquin, B.
    Milpied, N.
    Vrhovac, R.
    Harousseau, J. L.
    Moreau, P.
    Coste-Burel, M.
    Imbert-Marcille, B. M.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S287 - S287
  • [10] Pre-emptive treatment with rituximab for Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation: a safety and efficacy study
    Ganguly, S.
    DuBois, L.
    Divine, C.
    Aljitawi, O.
    Abhyankar, S.
    McGuirk, J.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S225 - S225
12345